Literature DB >> 7739292

The chemical and biological properties of hypericin--a compound with a broad spectrum of biological activities.

G Lavie1, Y Mazur, D Lavie, D Meruelo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7739292     DOI： 10.1002/med.2610150203

Source DB:  PubMed          Journal:  Med Res Rev        ISSN： 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  14 in total

1.  Topically applied hypericin exhibits skin penetrability on nude mice.

Authors:  Zhuo-Heng Li; Yuan-Yuan Li; Min Hou; Tao Yang; Lai-Chun Lu; Xiao-Yu Xu
Journal:  Lasers Med Sci       Date:  2018-06-13       Impact factor: 3.161

2.  First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent.

Authors:  Yicheng Ni; Dieter Huyghe; Kristin Verbeke; Peter A de Witte; Johan Nuyts; Luc Mortelmans; Feng Chen; Guy Marchal; Alfons M Verbruggen; Guy M Bormans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

3.  Application of new technology in bladder cancer diagnosis and treatment.

Authors:  Alvin C Goh; Seth P Lerner
Journal:  World J Urol       Date:  2009-02-22       Impact factor: 4.226

Review 4.  Hypericins as potential leads for new therapeutics.

Authors:  Anastasia Karioti; Anna Rita Bilia
Journal:  Int J Mol Sci       Date:  2010-02-04       Impact factor: 5.923

5.  Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model.

Authors:  Chad D Cole; James K Liu; Xiaoming Sheng; Steven S Chin; Meic H Schmidt; Martin H Weiss; William T Couldwell
Journal:  J Neurooncol       Date:  2008-01-29       Impact factor: 4.130

6.  Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.

Authors:  Marlein Miranda Cona; Yeranddy Aguiar Alpizar; Junjie Li; Matthias Bauwens; Yuanbo Feng; Ziping Sun; Jian Zhang; Feng Chen; Karel Talavera; Peter de Witte; Alfons Verbruggen; Raymond Oyen; Yicheng Ni
Journal:  Pharm Res       Date:  2013-08-09       Impact factor: 4.200

7.  Inhibition of prostaglandin E(2) production by anti-inflammatory hypericum perforatum extracts and constituents in RAW264.7 Mouse Macrophage Cells.

Authors:  Kimberly D P Hammer; Matthew L Hillwig; Avery K S Solco; Philip M Dixon; Kathleen Delate; Patricia A Murphy; Eve S Wurtele; Diane F Birt
Journal:  J Agric Food Chem       Date:  2007-08-15       Impact factor: 5.279

8.  In vivo molecular imaging of apoptosis and necrosis in atherosclerotic plaques using microSPECT-CT and microPET-CT imaging.

Authors:  M De Saint-Hubert; M Bauwens; N Deckers; M Drummen; K Douma; P Granton; G Hendrikx; D Kusters; J Bucerius; C P M Reutelingsperger; F M Mottaghy
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

9.  Elucidation of the tumoritropic principle of hypericin.

Authors:  M Van de Putte; T Roskams; J R Vandenheede; P Agostinis; P A M de Witte
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

Review 10.  Photodynamic inactivation of mammalian viruses and bacteriophages.

Authors:  Liliana Costa; Maria Amparo F Faustino; Maria Graça P M S Neves; Angela Cunha; Adelaide Almeida
Journal:  Viruses       Date:  2012-06-26       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.